#$%^&*AU2015249039B220160623.pdf#####ABSTRACT A hemostatic pad comprising a bioabsorbable scaffolding material； a lyophilized thrombin powder, a lyophilized fibrinogen powder, and a meltable binder powder, with all powders disposed on the bioabsorbable scaffolding material. A meltable binder such as PEG bonds the lyophilized thrombin powder and the lyophilized fibrinogen powder to the bioabsorbable scaffolding material for improved friability, wettability and performance in a use, such as for hemostatic treatment or sealing at a wound site.1/3 FIG. I Individual Value Plot of Tissue Peel Force (Nm) Compiled data of May 16,2011 1501401300 120. 121.5 :orce (N/m) 110- p=0.007 1009080Nominal FP dose Nominal FP dose Group
